SonoScape Medical Corp. (SHE:300633)

Market Cap	12.54B
Revenue (ttm)	2.05B
Net Income (ttm)	242.81M
Shares Out	430.64M
EPS (ttm)	0.56
PE Ratio	52.13
Forward PE	28.31
Dividend	0.32 (1.06%)
Ex-Dividend Date	May 29, 2024

Volume	6,123,700
Average Volume	6,666,104
Open	29.85
Previous Close	30.15
Day's Range	28.95 - 30.10
52-Week Range	25.04 - 44.07
Beta	-0.29
RSI	52.24
Earnings Date	Apr 12, 2025

About SonoScape Medical

SonoScape Medical Corp. engages in the research and development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound diagnostic equipment, such as MRI, X-ray machine, and ultrasound; digestive and respiratory endoscopy products that includes gastroscopes, colonoscopes, bronchoscopes, etc.; minimally invasive surgical products, such as laparoscopes, thoracoscopes, hysteroscopes, arthroscopes, etc. for used in general surgery, thoracic surgery, urology and other departments; and car...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,697
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300633

Financial Performance

In 2023, SonoScape Medical's revenue was 2.12 billion, an increase of 20.29% compared to the previous year's 1.76 billion. Earnings were 454.44 million, an increase of 22.88%.